Analyst Price Targets — CVRX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 11:53 am | William Plovanic | Canaccord Genuity | $10.00 | $5.69 | TheFly | CVRx price target lowered to $10 from $11 at Canaccord |
| November 6, 2025 1:45 pm | Ross Osborn | Cantor Fitzgerald | $13.00 | $9.98 | TheFly | CVRx price target raised to $13 from $11 at Cantor Fitzgerald |
| October 30, 2024 7:55 am | Matt O'Brien | Piper Sandler | $16.00 | $12.90 | StreetInsider | CVRx Inc (CVRX) PT Raised to $16 at Piper Sandler |
| September 10, 2024 7:48 am | Ross Osborn | Cantor Fitzgerald | $14.00 | $7.96 | TheFly | Cantor starts CVRx with Overweight on heart failure potential |
| July 30, 2024 6:51 am | Matt O'Brien | Piper Sandler | $13.00 | $9.27 | TheFly | CVRx price target lowered to $13 from $15 at Piper Sandler |
| July 30, 2024 6:27 am | William Plovanic | Canaccord Genuity | $15.00 | $9.27 | StreetInsider | CVRx Inc (CVRX) PT Raised to $15 at Canaccord Genuity |
| July 11, 2024 8:41 am | Frank Takkinen | Lake Street | $12.00 | $7.59 | TheFly | CVRx price target lowered to $12 from $18 at Lake Street |
| June 5, 2024 9:07 am | Frank Takkinen | Loop Capital Markets | $18.00 | $8.00 | StreetInsider | CVRx Inc (CVRX) PT Lowered to $18 at Lake Street Capital Markets |
| May 1, 2024 6:57 am | Chase Knickerbocker | Craig-Hallum | $23.00 | $9.27 | StreetInsider | Craig-Hallum Assumes CVRx Inc (CVRX) at Buy |
Latest News for CVRX
CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CVRx, Inc. (CVRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Jared Oasheim, the Company's Chief Financial Officer, will be stepping down from his role to pursue other professional opportunities.
MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Jared Oasheim, the Company's Chief Financial Officer, will be stepping down from his role to pursue other professional opportunities. To…
MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami on Wednesday, June 10, 2026. The…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CVRX.
U.S. House Trading
No House trades found for CVRX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.